Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1217165.RA72OENaj423lZllcU0MJGhJzvM3qm4qFUiB38D_HCFBU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1217165.RA72OENaj423lZllcU0MJGhJzvM3qm4qFUiB38D_HCFBU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1217165.RA72OENaj423lZllcU0MJGhJzvM3qm4qFUiB38D_HCFBU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1217165.RA72OENaj423lZllcU0MJGhJzvM3qm4qFUiB38D_HCFBU130_provenance.
- NP1217165.RA72OENaj423lZllcU0MJGhJzvM3qm4qFUiB38D_HCFBU130_assertion description "[Chitinase 3-like 1 (CHI3L1) is validated as a prognostic marker of conversion to MS, and immunoglobulin M oligoclonal bands and L-selectin could be incorporated as possible measures of the risk stratification strategy in patients treated with natalizumab.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217165.RA72OENaj423lZllcU0MJGhJzvM3qm4qFUiB38D_HCFBU130_provenance.
- NP1217165.RA72OENaj423lZllcU0MJGhJzvM3qm4qFUiB38D_HCFBU130_assertion evidence source_evidence_literature NP1217165.RA72OENaj423lZllcU0MJGhJzvM3qm4qFUiB38D_HCFBU130_provenance.
- NP1217165.RA72OENaj423lZllcU0MJGhJzvM3qm4qFUiB38D_HCFBU130_assertion SIO_000772 25190340 NP1217165.RA72OENaj423lZllcU0MJGhJzvM3qm4qFUiB38D_HCFBU130_provenance.
- NP1217165.RA72OENaj423lZllcU0MJGhJzvM3qm4qFUiB38D_HCFBU130_assertion wasDerivedFrom befree-2016 NP1217165.RA72OENaj423lZllcU0MJGhJzvM3qm4qFUiB38D_HCFBU130_provenance.
- NP1217165.RA72OENaj423lZllcU0MJGhJzvM3qm4qFUiB38D_HCFBU130_assertion wasGeneratedBy ECO_0000203 NP1217165.RA72OENaj423lZllcU0MJGhJzvM3qm4qFUiB38D_HCFBU130_provenance.
- befree-2016 importedOn "2016-02-19" NP1217165.RA72OENaj423lZllcU0MJGhJzvM3qm4qFUiB38D_HCFBU130_provenance.